ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Five Contracts Funded Under Unconventional Innovations Program

October 22, 1999

GAO Calls For Stronger FDA Enforcement Of Accelerated Approval Followup Studies

October 30, 2009

Mammography Had Limited Impact Among Swedish Women Age 40-69

July 27, 2012

Mothers’ Smoking, Depression Influences Teen Smoking

May 28, 2010

Conversation With The Cancer Letter: Ronald DePinho Says Moon Shots Will Go On

January 18, 2013

Final Issue of ‘78

December 15, 1978